We previously showed that combination treatment with a pan-Pim kinase inhibitor increases apoptosis induction by topoisomerase 2 inhibitor chemotherapy drugs, including anthracyclines used in AML remission induction therapy, in cells with FLT3-ITD [13]. The gene discussed is FLT3; the disease is acute myeloid leukemia.